Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Elevated Atopic Comorbidity in Patients with Food Protein-Induced Enterocolitis.

Ruffner MA, Wang KY, Dudley JW, Cianferoni A, Grundmeier RW, Spergel JM, Brown-Whitehorn TF, Hill DA.

J Allergy Clin Immunol Pract. 2019 Nov 20. pii: S2213-2198(19)30945-6. doi: 10.1016/j.jaip.2019.10.047. [Epub ahead of print]

PMID:
31759160
2.

Non-Ige Mediated Food Allergy.

Cianferoni A.

Curr Pediatr Rev. 2019 Oct 30. doi: 10.2174/1573396315666191031103714. [Epub ahead of print]

PMID:
31670623
3.

Eosinophilic esophagitis: early diagnosis is the key.

Muir AB, Brown-Whitehorn T, Godwin B, Cianferoni A.

Clin Exp Gastroenterol. 2019 Aug 15;12:391-399. doi: 10.2147/CEG.S175061. eCollection 2019.

4.

Precision medicine in atopic diseases.

Cianferoni A, Annesi-Maesano I.

Curr Opin Allergy Clin Immunol. 2019 Dec;19(6):654-664. doi: 10.1097/ACI.0000000000000591.

PMID:
31573992
5.

Food protein-induced enterocolitis syndrome.

Caubet JC, Cianferoni A, Groetch M, Nowak-Wegrzyn A.

Clin Exp Allergy. 2019 Sep;49(9):1178-1190. doi: 10.1111/cea.13415. Review.

PMID:
31468626
6.

Food protein-induced enterocolitis syndrome in the US population-based study.

Nowak-Wegrzyn A, Warren CM, Brown-Whitehorn T, Cianferoni A, Schultz-Matney F, Gupta RS.

J Allergy Clin Immunol. 2019 Oct;144(4):1128-1130. doi: 10.1016/j.jaci.2019.06.032. Epub 2019 Jul 6. No abstract available.

PMID:
31288044
7.

A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals.

Andorf S, Purington N, Kumar D, Long A, O'Laughlin KL, Sicherer S, Sampson H, Cianferoni A, Whitehorn TB, Petroni D, Makhija M, Robison RG, Lierl M, Logsdon S, Desai M, Galli SJ, Rael E, Assa'ad A, Chinthrajah S, Pongracic J, Spergel JM, Tam J, Tilles S, Wang J, Nadeau K.

EClinicalMedicine. 2019 Jan 21;7:27-38. doi: 10.1016/j.eclinm.2018.12.006. eCollection 2019 Jan.

8.

Efficacy of Epicutaneous Immunotherapy in Children With Milk-Induced Eosinophilic Esophagitis.

Spergel JM, Elci OU, Muir AB, Liacouras CA, Wilkins BJ, Burke D, Lewis MO, Brown-Whitehorn T, Cianferoni A.

Clin Gastroenterol Hepatol. 2019 May 14. pii: S1542-3565(19)30524-5. doi: 10.1016/j.cgh.2019.05.014. [Epub ahead of print]

PMID:
31100455
9.

Peanut-allergic patient experiences after epicutaneous immunotherapy: peanut consumption and impact on QoL.

Lewis MO, Brown-Whitehorn TF, Cianferoni A, Rooney C, Spergel JM.

Ann Allergy Asthma Immunol. 2019 Jul;123(1):101-103. doi: 10.1016/j.anai.2019.04.006. Epub 2019 Apr 10. No abstract available.

10.

Modified oral enteric-coated budesonide regimens to treat pediatric eosinophilic gastroenteritis, a single center experience.

Kennedy K, Muir AB, Grossman A, Brown-Whitehorn T, Cianferoni A, Spergel JM, Furuta GT, Wilkins BJ, Shuker M, Ruffner MA.

J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):2059-2061. doi: 10.1016/j.jaip.2019.01.053. Epub 2019 Feb 11. No abstract available.

PMID:
30763733
11.

Food avoidance strategies in eosinophilic oesophagitis.

Cianferoni A, Shuker M, Brown-Whitehorn T, Hunter H, Venter C, Spergel JM.

Clin Exp Allergy. 2019 Mar;49(3):269-284. doi: 10.1111/cea.13360. Review.

PMID:
30714219
12.

Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α.

Kasagi Y, Dods K, Wang JX, Chandramouleeswaran PM, Benitez AJ, Gambanga F, Kluger J, Ashorobi T, Gross J, Tobias JW, Klein-Szanto AJ, Spergel JM, Cianferoni A, Falk GW, Whelan KA, Nakagawa H, Muir AB.

J Allergy Clin Immunol. 2019 Jul;144(1):171-182. doi: 10.1016/j.jaci.2018.10.067. Epub 2018 Dec 20.

PMID:
30578874
13.

Fruit for thought: anaphylaxis to fruit pectin in foods.

Capucilli P, Kennedy K, Kazatsky AM, Cianferoni A, Spergel JM.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):719-720. doi: 10.1016/j.jaip.2018.11.047. Epub 2018 Dec 12. No abstract available.

PMID:
30553053
14.

Immunology of the ancestral differences in eosinophilic esophagitis.

Kottyan L, Spergel JM, Cianferoni A.

Ann Allergy Asthma Immunol. 2019 May;122(5):443-444. doi: 10.1016/j.anai.2018.10.026. Epub 2018 Nov 7. No abstract available.

PMID:
30414468
15.

Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications.

Ruffner MA, Kennedy K, Cianferoni A.

Expert Rev Clin Immunol. 2019 Jan;15(1):83-95. doi: 10.1080/1744666X.2019.1544893. Epub 2018 Nov 19.

PMID:
30394139
16.

Food Protein-Induced Enterocolitis Syndrome Food Challenges: Experience from a Large Referral Center.

Wang KY, Lee J, Cianferoni A, Ruffner MA, Dean A, Molleston JM, Pawlowski NA, Heimall J, Saltzman RW, Ram GS, Fiedler J, Gober LM, Spergel JM, Brown-Whitehorn TF.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):444-450. doi: 10.1016/j.jaip.2018.09.009. Epub 2018 Sep 20.

PMID:
30243880
17.

Comparison of comorbid diagnoses in children with and without eosinophilic esophagitis in a large population.

Capucilli P, Cianferoni A, Grundmeier RW, Spergel JM.

Ann Allergy Asthma Immunol. 2018 Dec;121(6):711-716. doi: 10.1016/j.anai.2018.08.022. Epub 2018 Sep 6.

PMID:
30194971
18.

Differences in egg and milk food challenge outcomes based on tolerance to the baked form.

Capucilli P, Cianferoni A, Fiedler J, Gober L, Pawlowski N, Ram G, Saltzman R, Spergel JM, Heimall J.

Ann Allergy Asthma Immunol. 2018 Nov;121(5):580-587. doi: 10.1016/j.anai.2018.07.018. Epub 2018 Jul 21.

PMID:
30036581
19.

A Review of Tertiary Referrals for Management of Pediatric Esophageal Eosinophilia.

Godwin B, Liacouras C, Mehta V, Eisenberg J, Agawu A, Brown-Whitehorn T, Ruffner MA, Verma R, Cianferoni A, Spergel JM, Muir AB.

Front Pediatr. 2018 Jun 20;6:173. doi: 10.3389/fped.2018.00173. eCollection 2018.

20.

New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting.

Spergel JM, Aceves SS, Kliewer K, Gonsalves N, Chehade M, Wechsler JB, Groetch M, Friedlander J, Dellon ES, Book W, Hirano I, Muir AB, Cianferoni A, Spencer L, Liacouras CA, Cheng E, Kottyan L, Wen T, Platts-Mills T, Rothenberg ME.

J Allergy Clin Immunol. 2018 Jul;142(1):48-53. doi: 10.1016/j.jaci.2018.05.005. Epub 2018 May 24.

21.

EMSY is increased and activates TSLP & CCL5 expression in eosinophilic esophagitis.

Fahey LM, Guzek R, Ruffner MA, Sullivan KE, Spergel J, Cianferoni A.

Pediatr Allergy Immunol. 2018 Aug;29(5):565-568. doi: 10.1111/pai.12907. Epub 2018 May 29. No abstract available.

PMID:
29663593
22.

Improving Anaphylaxis Care: The Impact of a Clinical Pathway.

Lee J, Rodio B, Lavelle J, Lewis MO, English R, Hadley S, Molnar J, Jacobstein C, Cianferoni A, Spergel J, Zielinski L, Tsarouhas N, Brown-Whitehorn T.

Pediatrics. 2018 May;141(5). pii: e20171616. doi: 10.1542/peds.2017-1616. Epub 2018 Apr 3.

23.

Food allergen triggers are increased in children with the TSLP risk allele and eosinophilic esophagitis.

Fahey LM, Chandramouleeswaran PM, Guan S, Benitez AJ, Furuta GT, Aceves SS, Wang ML, Liacouras CA, Muir AB, Sleiman PM, Hakonarson H, Spergel JM, Cianferoni A.

Clin Transl Gastroenterol. 2018 Mar 6;9(3):139. doi: 10.1038/s41424-018-0003-x.

24.

Increase of natural killer cells in children with liver transplantation-acquired food allergy.

Mori F, Angelucci C, Cianferoni A, Barni S, Indolfi G, Casini A, Mangone G, Materassi M, Pucci N, Azzari C, Novembre E.

Allergol Immunopathol (Madr). 2018 Sep - Oct;46(5):447-453. doi: 10.1016/j.aller.2017.09.030. Epub 2018 Feb 16.

PMID:
29456038
25.

The urgent need for a harmonized severity scoring system for acute allergic reactions.

Muraro A, Fernandez-Rivas M, Beyer K, Cardona V, Clark A, Eller E, Hourihane JOB, Jutel M, Sheikh A, Agache I, Allen KJ, Angier E, Ballmer-Weber B, Bilò MB, Bindslev-Jensen C, Camargo CA Jr, Cianferoni A, DunnGalvin A, Eigenmann PA, Halken S, Hoffmann-Sommergruber K, Lau S, Nilsson C, Poulsen LK, Rueff F, Spergel J, Sturm G, Timmermans F, Torres MJ, Turner P, van Ree R, Wickman M, Worm M, Mills ENC, Roberts G.

Allergy. 2018 Sep;73(9):1792-1800. doi: 10.1111/all.13408. Epub 2018 Jun 17. Review.

26.

Elevated expression of activated TH2 cells and milk-specific TH2 cells in milk-induced eosinophilic esophagitis.

Cianferoni A, Ruffner MA, Guzek R, Guan S, Brown-Whitehorn T, Muir A, Spergel JM.

Ann Allergy Asthma Immunol. 2018 Feb;120(2):177-183.e2. doi: 10.1016/j.anai.2017.11.006. Epub 2017 Dec 28.

27.

Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.

Bird JA, Spergel JM, Jones SM, Rachid R, Assa'ad AH, Wang J, Leonard SA, Laubach SS, Kim EH, Vickery BP, Davis BP, Heimall J, Cianferoni A, MacGinnitie AJ, Crestani E, Burks AW; ARC001 Study Group.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):476-485.e3. doi: 10.1016/j.jaip.2017.09.016. Epub 2017 Oct 31.

28.

Clinical tolerance in eosinophilic esophagitis.

Ruffner MA, Brown-Whitehorn TF, Verma R, Cianferoni A, Gober L, Shuker M, Muir AB, Liacouras CA, Spergel JM.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):661-663. doi: 10.1016/j.jaip.2017.06.035. Epub 2017 Aug 12. No abstract available.

29.

Invariant natural killer cells change after an oral allergy desensitization protocol for cow's milk.

Cianferoni A, Saltzman R, Saretta F, Barni S, Dudek E, Kelleher M, Spergel JM.

Clin Exp Allergy. 2017 Nov;47(11):1390-1397. doi: 10.1111/cea.12975. Epub 2017 Aug 23.

PMID:
28685970
30.

Side effects and their impact on the success of milk oral immunotherapy (OIT) in children.

Mori F, Cianferoni A, Brambilla A, Barni S, Sarti L, Pucci N, de Martino M, Novembre E.

Int J Immunopathol Pharmacol. 2017 Jun;30(2):182-187. doi: 10.1177/0394632017697986. Epub 2017 Mar 14.

31.

Inflammatory events during food protein-induced enterocolitis syndrome reactions.

Pecora V, Prencipe G, Valluzzi R, Dahdah L, Insalaco A, Cianferoni A, De Benedetti F, Fiocchi A.

Pediatr Allergy Immunol. 2017 Aug;28(5):464-470. doi: 10.1111/pai.12723. Epub 2017 Jun 22.

PMID:
28375580
32.

Eosinophilic Esophagitis: A Primary Disease of the Esophageal Mucosa.

Abonia JP, Spergel JM, Cianferoni A.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):951-955. doi: 10.1016/j.jaip.2017.02.004. Epub 2017 Mar 28. Review. No abstract available.

33.

International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: Executive summary-Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology.

Nowak-Węgrzyn A, Chehade M, Groetch ME, Spergel JM, Wood RA, Allen K, Atkins D, Bahna S, Barad AV, Berin C, Brown Whitehorn T, Burks AW, Caubet JC, Cianferoni A, Conte M, Davis C, Fiocchi A, Grimshaw K, Gupta R, Hofmeister B, Hwang JB, Katz Y, Konstantinou GN, Leonard SA, Lightdale J, McGhee S, Mehr S, Sopo SM, Monti G, Muraro A, Noel SK, Nomura I, Noone S, Sampson HA, Schultz F, Sicherer SH, Thompson CC, Turner PJ, Venter C, Westcott-Chavez AA, Greenhawt M.

J Allergy Clin Immunol. 2017 Apr;139(4):1111-1126.e4. doi: 10.1016/j.jaci.2016.12.966. Epub 2017 Feb 4.

34.

Omalizumab facilitates rapid oral desensitization for peanut allergy.

MacGinnitie AJ, Rachid R, Gragg H, Little SV, Lakin P, Cianferoni A, Heimall J, Makhija M, Robison R, Chinthrajah RS, Lee J, Lebovidge J, Dominguez T, Rooney C, Lewis MO, Koss J, Burke-Roberts E, Chin K, Logvinenko T, Pongracic JA, Umetsu DT, Spergel J, Nadeau KC, Schneider LC.

J Allergy Clin Immunol. 2017 Mar;139(3):873-881.e8. doi: 10.1016/j.jaci.2016.08.010. Epub 2016 Sep 5.

35.

Oral viscous budesonide can be successfully delivered through a variety of vehicles to treat eosinophilic esophagitis in children.

Lee J, Shuker M, Brown-Whitehorn T, Cianferoni A, Gober L, Muir A, Verma R, Liacouras C, Spergel JM.

J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):767-8. doi: 10.1016/j.jaip.2016.02.005. Epub 2016 Mar 26. No abstract available.

PMID:
27025298
36.

Wheat allergy: diagnosis and management.

Cianferoni A.

J Asthma Allergy. 2016 Jan 29;9:13-25. doi: 10.2147/JAA.S81550. eCollection 2016. Review.

37.

Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity.

Simon D, Cianferoni A, Spergel JM, Aceves S, Holbreich M, Venter C, Rothenberg ME, Terreehorst I, Muraro A, Lucendo AJ, Schoepfer A, Straumann A, Simon HU.

Allergy. 2016 May;71(5):611-20. doi: 10.1111/all.12846. Epub 2016 Feb 25. Review.

PMID:
26799684
38.

Recent advances in the pathological understanding of eosinophilic esophagitis.

Cianferoni A, Spergel JM, Muir A.

Expert Rev Gastroenterol Hepatol. 2015;9(12):1501-10. doi: 10.1586/17474124.2015.1094372. Epub 2015 Oct 15. Review.

39.

Food allergy to uncommonly challenged foods is rare based on oral food challenge.

Ram G, Cianferoni A, Spergel JM.

J Allergy Clin Immunol Pract. 2016 Jan-Feb;4(1):156-7.e5. doi: 10.1016/j.jaip.2015.07.017. Epub 2015 Sep 3. No abstract available.

PMID:
26342742
40.

From genetics to treatment of eosinophilic esophagitis.

Cianferoni A, Spergel JM.

Curr Opin Allergy Clin Immunol. 2015 Oct;15(5):417-25. doi: 10.1097/ACI.0000000000000200.

41.

Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis.

Ram G, Lee J, Ott M, Brown-Whitehorn TF, Cianferoni A, Shuker M, Wang ML, Verma R, Liacouras CA, Spergel JM.

Ann Allergy Asthma Immunol. 2015 Sep;115(3):224-228.e1. doi: 10.1016/j.anai.2015.07.004. Epub 2015 Jul 30.

PMID:
26235409
42.

Eosinophilic Esophagitis and Gastroenteritis.

Cianferoni A, Spergel JM.

Curr Allergy Asthma Rep. 2015 Sep;15(9):58. doi: 10.1007/s11882-015-0558-5. Review.

PMID:
26233430
43.

Eosinophilic Esophagitis: A Comprehensive Review.

Cianferoni A, Spergel J.

Clin Rev Allergy Immunol. 2016 Apr;50(2):159-74. doi: 10.1007/s12016-015-8501-z. Review.

PMID:
26194940
44.

Azithromycin is more allergenic than clarithromycin in children with suspected hypersensitivity reaction to macrolides.

Barni S, Butti D, Mori F, Pucci N, Rossi ME, Cianferoni A, Novembre E.

J Investig Allergol Clin Immunol. 2015;25(2):128-32.

45.

Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions.

Mori F, Cianferoni A, Barni S, Pucci N, Rossi ME, Novembre E.

J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):375-80.e1. doi: 10.1016/j.jaip.2014.11.001. Epub 2015 Jan 16.

PMID:
25609343
46.

The development of IgE-mediated immediate hypersensitivity after the diagnosis of eosinophilic esophagitis to the same food.

Hill DA, Shuker M, Cianferoni A, Wong T, Ruchelli E, Spergel JM, Brown-Whitehorn TF.

J Allergy Clin Immunol Pract. 2015 Jan-Feb;3(1):123-4. doi: 10.1016/j.jaip.2014.08.005. Epub 2014 Oct 3. No abstract available.

47.

Egg Food Challenges are Associated with More Gastrointestinal Reactions.

Gupta M, Grossmann LD, Spergel JM, Cianferoni A.

Children (Basel). 2015 Aug 17;2(3):371-81. doi: 10.3390/children2030371.

48.

GWAS identifies four novel eosinophilic esophagitis loci.

Sleiman PM, Wang ML, Cianferoni A, Aceves S, Gonsalves N, Nadeau K, Bredenoord AJ, Furuta GT, Spergel JM, Hakonarson H.

Nat Commun. 2014 Nov 19;5:5593. doi: 10.1038/ncomms6593.

49.

The importance of TSLP in allergic disease and its role as a potential therapeutic target.

Cianferoni A, Spergel J.

Expert Rev Clin Immunol. 2014 Nov;10(11):1463-74. doi: 10.1586/1744666X.2014.967684. Review.

50.

Immunotherapeutic approaches for the treatment of eosinophilic esophagitis.

Cianferoni A, Spergel JM.

Immunotherapy. 2014;6(3):321-31. doi: 10.2217/imt.14.3. Review.

Supplemental Content

Loading ...
Support Center